A model-based simulation of glycaemic control and body weight when switching from semaglutide to 3.0- and 4.5-mg doses of once-weekly dulaglutide.
Lai San ThamKevin M PantaloneKathleen M DunganKashif M MunirCheng Cai TangManige KonigAnita Y M KwanPublished in: Diabetes, obesity & metabolism (2021)
Switching from semaglutide 0.5 mg to dulaglutide 3.0 or 4.5 mg with dose escalation potentially yields additional HbA1c and weight reductions; switching from semaglutide 1.0 mg to dulaglutide 4.5 mg may enhance weight loss.